The Power of Truth® has been released for sale and assignment to a conservative pro-American news outlet, cable network, or other media outlet that wants to define and brand its operation as the bearer of the truth, and set itself above the competition.

In every news story the audience hears of censorship, speech, and the truth. The Power of Truth® has significant value to define an outlet, and expand its audience. A growing media outlet may decide to rebrand their operation The Power of Truth®. An established outlet may choose to make it the slogan distinguishing their operation from the competition. You want people to think of your outlet when they hear it, and think of the slogan when they see your company name. It is the thing which answers the consumer's questions: Why should I choose you? Why should I listen to you? Think:

  • What’s in your wallet -- Capital One
  • The most trusted name in news – CNN
  • Fair and balanced - Fox News
  • Where’s the beef -- Wendy’s
  • You’re in good hands -- Allstate
  • The ultimate driving machine -- BMW

The Power of Truth® is registered at the federal trademark level in all applicable trademark classes, and the sale and assignment includes the applicable domain names. The buyer will have both the trademark and the domains so that it will control its business landscape without downrange interference.

Contact: Truth@ThePowerOfTruth.com

Sunday, December 22, 2024
Sunday, December 22, 2024

An intensive three-year intervention to lower the top blood pressure number to less than 120 mm Hg was more effective at preventing death, heart attack, stroke and other cardiovascular events in adults at high risk for cardiovascular disease, compared to the standard treatment target of under 140 mm Hg, according to new research.
Read more …Reducing systolic blood pressure to less than 120 mm Hg reduced cardiovascular event risk

Intratumoral therapy -- in which cancer drugs are injected directly into tumors -- is a promising treatment option for solid cancers but has shown limited success in clinical trials due to an inability to precisely deliver the drug and because most immunotherapies quickly dissipate from the site of injection. A team of researchers has developed a gel delivery system that overcomes these challenges. The gel is injectable but solidifies upon delivery; contains an imaging agent for visualization under CT scan; and can hold a high concentration of drug for slow, controlled release.
Read more …Researchers develop gel to deliver cancer drugs for solid tumors

More Articles …

  1. Hormonal contraceptives in teens may alter risk assessment, rat study suggests
  2. Appropriate statin prescriptions increase sixfold with automated referrals
  3. Scientists discover key to a potential natural cancer treatment's potency
  4. Antiviral treatment is largely underused in children with influenza, study findings show
  5. AI programs spat out known data and hardly learned specific chemical interactions when predicting drug potency
  6. Cycle of fasting and feeding is crucial for healthy aging
Page 980 of 1171